Search
Research
Characterising quality of life and its determinants for children with intellectual disability and their familiesAndrew Helen Jenny Peter Videos Whitehouse Watch and listen to Andrew Leonard Downs Jacoby PhD MBChB MPH BApplSci (physio) MSc PhD BA (Hons) MSc
Research
Working towards a shared framework in the diagnosis of neurodevelopmental disorders in Australia: A Gap AnalysisAmy Andrew Carol Jacinta Videos Finlay-Jones Whitehouse Watch and listen to Andrew Bower Freeman BPsych(Hons), MPsych(Clinical), MHealthEcon, PhD (
Research
“Beacon” Cyber App Project with BankwestThe Kids Research Institute Australia and Bankwest partnered together from 2019-2022 to develop a cyber safety app that provides parents and carers with the knowledge and skills to help their children thrive in a digital world.
Research
Playful BytesNurturing children's health together: A collaboration between early childhood education and care (ECEC) educators and parents on active play and eating well
Research
Type 1 and Type 2 Diabetes DNA bankA register which stores demographic and clinical data on all patients attending the diabetes clinic at Princess Margaret Hospital
Research
Sprint proof of concept studyThis study will evaluate the effect of two types of aerobic exercise
Research
Epigenetic changes underpinning allergen sensitization: a twin-based studyWe are studying immune cells from identical twins of which one suffers and one does not suffer from allergic disease to identify specific mechanisms that may play important roles in disease development.
This research project was part of the broader Ngulluk Koolunga Ngulluk Koort (Our Children, Our Heart) five-year (2016 to 2020) project.
Research
Child development at school entry and student wellbeing six years laterIt has been well established that children's development at school entry is associated with their later academic achievement, but less is known about whether there is also an association with other measures of school success, such as students' social and emotional wellbeing.
Research
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical